Company Overview More
Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company’s lead program is xB3-001, an xB3 peptide vector-trastuzumab fusion. It is developing xB3, a platform technology for the delivery of therapeutics across the blood-brain barrier (BBB); and the treatment of central nervous system disorders, including brain cancers, and metabolic and neurodegenerative diseases. The company’s in-house development programs develop symptomatic and disease-modifying treatments for brain metastases, glioblastomas, and neurodegenerative diseases. Bioasis Technologies Inc. has a collaborative research agreement with CQDM and Brain Canada to search for a platform for BBB delivery of therapeutics; and BioAgilytix for the development and validation of bioanalytical methods to support and advance the xB3 TM-001 program, as well as with the WuXi Biologics (Hong Kong) Limited for the manufacture of xB3-001 to treat brain cancer. The company was founded in 2007 and is headquartered in Guilford, Connecticut.
CEO: Rathjen B.Sc. (Hons.), Q.C., Ph.D., M.A.I.C.D., FTSE, Deborah Ann
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

BTI British American Tobacco

42.500+0.140+0.33%
Trading Session 05/16 11:18 ET
High
42.516
Open
42.270
Turnover
37.11M
Low
42.230
Pre Close
42.360
Volume
875.86K
Market Cap
97.52B
P/E(TTM)
10.96
52wk High
46.405
Shares
2.29B
P/E(Static)
10.96
52wk Low
32.373
Float Cap
86.38B
Bid/Ask %
-85.19%
Historical High
53.444
Shs Float
2.03B
Volume Ratio
0.67
Historical Low
1.261
Dividend TTM
2.944
Div Yield TTM
900
P/B
1.14
Dividend LFY
6.93%
Div Yield LFY
2117.65%
Turnover Ratio
0.04%
Amplitude
0.68%
Avg Price
42.367
Lot Size
1
Float Cap
86.38B
Bid/Ask %
-85.19%
Historical High
53.444
Shs Float
2.03B
Volume Ratio
0.67
Historical Low
1.261
Dividend TTM
2.944
P/B
1.14
Dividend LFY
6.93%
Turnover Ratio
0.04%
Amplitude
0.68%
Avg Price
42.367
Lot Size
1
Price Forecast

Loading...

News

Comment